Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mohammed K. Manzoor"'
Publikováno v:
Pharmacology of Immunotherapeutic Drugs ISBN: 9783030199210
Autoimmune disease is thought to affect more than 5% of the world’s population, and thus represents a significant healthcare burden. Autoimmunity results from an inappropriate immune response to self-antigens (also called autoantigens), which resul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c76f3ef8353171a4443e0efa17ecaad
https://doi.org/10.1007/978-3-030-19922-7_7
https://doi.org/10.1007/978-3-030-19922-7_7
Publikováno v:
Inflammation. 39:2053-2061
Pro-inflammatory mediators including TNF-alpha, IL-6, and nitric oxide are important for the regulation of the immune response when an infection is present, but when overproduced, it can be responsible for the development of tissue and organ injury s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::170953353968ebbbc6962f925625e438
https://doi.org/10.1007/s10753-016-0443-y
https://doi.org/10.1007/s10753-016-0443-y
Autor:
Andrea Aquilato, Ola Ghoneim, Ivan O. Edafiogho, Patricia Jackson, Mohammed K. Manzoor, Doreen E. Szollosi
Publikováno v:
The Journal of pharmacy and pharmacology. 70(1)
ObjectivesMany studies of disease state mechanisms reveal that unbridled inflammation is to blame for many of the symptoms associated with autoimmune diseases such as Crohn’s and Rheumatoid Arthritis (RA). While therapies aimed at decreasing levels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd88e8d7a0df50bf00b8fbc54fff78f3
https://pubmed.ncbi.nlm.nih.gov/28872680
https://pubmed.ncbi.nlm.nih.gov/28872680
Publikováno v:
The FASEB Journal. 29
Prior research has shown E121, a novel enaminone compound has immunosuppressive ability and potential as a novel therapeutic drug for inflammatory diseases. E121 has shown significant reduction of ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c680e1ced6c6abf2c42333e97c29d74
https://doi.org/10.1096/fasebj.29.1_supplement.716.5
https://doi.org/10.1096/fasebj.29.1_supplement.716.5